2021 Third Quarter Earnings (Unaudited) October 26, 2021 -- 1 of 16 -- 22 2021 Q3 Earnings – October 26, 2021. All rights reserved. Events 2021 Earnings Calls Q4 January 25 -- 2 of 16 -- 33 2021 Q3 Earnings – October 26, 2021. All rights reserved. Forward looking statement This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2020, and any subsequent quarterly reports on Form 10-Q (the “Reports”); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials, labor, and energy (including oil and natural gas and their derivatives) due to shortages, increased demand and wages, logistics, manufacturing site disruption or supply chain interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company’s funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; and (14) tax-related external conditions, including changes in tax rates, laws or regulations. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8-K. The information contained in this presentation is as of the date indicated. The Company assumes no obligation to update any forward-looking statements contained in this presentation as a result of new information or future events or developments. This presentation refers to certain non-GAAP financial measures. Refer to 3M’s October 26, 2021, press release for descriptions of non-GAAP financial measures such free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures that adjust for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release. Note on non-GAAP financial measures -- 3 of 16 -- 44 2021 Q3 Earnings – October 26, 2021. All rights reserved. 3M delivers strong performance in a dynamic environment KEY TAKEAWAYS • Strong and growing segments delivered organic growth across all business groups and geographic areas • Delivered in the face of a challenging environment; focused on serving customers while navigating global supply chains, raw materials and logistics environment • Global end-market and customer demand remains strong • Semiconductor constraints impacting end-markets, particularly automotive and electronics; healthcare and oral care elective procedures expected to remain stable with recent trends • Gaining traction on selling price increases to help mitigate inflationary headwinds • Prioritizing investments in growth, productivity and sustainability • Updating full-year 2021 guidance range to reflect ongoing supply chain, raw materials and logistics challenges Organic local-currency growth Operating margin Earnings per share +6.3% / +11.5% 20.0% / 21.5% $2.45 / $7.81 Q3 / YTD -- 4 of 16 -- 55 2021 Q3 Earnings – October 26, 2021. All rights reserved. Our areas of investment align with key global trends Targeting growth above macro in attractive markets Automotive • Technologies to improve energy efficiency and help make transportation safer, smarter and more connected Home improvement • Innovations that help consumers personalize their homes and keep families healthier and more productive, including our fast-growing Command™ damage-free hanging solutions and Filtrete™ filter brands Personal safety • Science-based solutions for respiratory, face, hearing and fall protection Biopharma filtration • Innovations that help pharmaceutical companies advance the development and manufacturing of therapeutics and vaccines Electronics and software • Solutions that enable better performance and connectivity while improving productivity, speed and agility for customers -- 5 of 16 -- 66 2021 Q3 Earnings – October 26, 2021. All rights reserved. Q3 2021 operating margin and EPS +9.0% Operating Income Margin Earnings Per Share Q3 2020 22.9% $2.45 Organic volume/productivity and other -1.4% -$0.02 Q3 2021 organic volume +4.9; productivity penalties from global supply chain challenges; restructuring savings offsetting restructuring charge; increased investments in growth and sustainability; increased litigation-related costs Price/raw material -1.3% -$0.12 Selling price increases more than offset by higher raw materials and logistics costs FX -0.2% -$0.01 Net of hedge impact; full-year 2021 FX benefit of approximately $0.15 per share, remains unchanged Other expense/income NA +$0.08 Primarily non-operating pension benefit and lower net interest expense Tax rate* NA +$0.09 Q3 2021 tax rate 18.4% versus 21.5% in prior year; full-year 2021 tax rate expected in range of 18.5% to 19.5% vs. 20% to 21% previously Shares outstanding NA -$0.02 Average diluted shares up 1% Q3 2021 20.0% $2.45 * The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above. -- 6 of 16 -- 77 2021 Q3 Earnings – October 26, 2021. All rights reserved. Q3 2021 cash flow and balance sheet Proactive balance sheet management • Net debt of $12.4B, down $2.6B, or 17% year-on-year Adjusted free cash flow • Q3: $1.5B, down 29%; YTD: $4.5B, down 3% year-on-year Adjusted free cash flow conversion • Q3: 107%, down 44 ppts; YTD: 98%, down 26 ppts • Year-on-year decline primarily due to strong customer demand and supply chain challenges which increased working capital Capital expenditures • Q3: $343M; YTD $1.0B • FY 2021: $1.5B to $1.6B versus $1.8B to $2.0B, previously Cash returned to shareholders • Dividends: Q3 $856M; YTD $2.6B • Gross share repurchases: Q3 $527M; YTD $1.3B $1.5B -29% year-on-year Adjusted free cash flow 107% -44 ppts year-on-year Adjusted free cash flow conversion $1.4B +63% year-on-year Cash returned to shareholders -- 7 of 16 -- 88 2021 Q3 Earnings – October 26, 2021. All rights reserved. Q3 Business Group performance Organic Growth Segment Operating Margin Commentary Safety & Industrial +6.1% 19.2% • Organic growth led by general industrial with strength in adhesives and tapes, and abrasives; roofing granules down due to strong year-on-year comp; personal safety declined due to prior- year strong COVID-related respiratory demand • Disposable respirator sales declined 7% organically year-on-year, and 15% sequentially • Operating margins -6.5 ppts year-on-year; increases in raw materials, logistics and litigation- related costs, partially offset by sales growth Transportation & Electronics +5.1% 19.0% • Organic growth led by advanced materials, commercial solutions, transportation safety; auto OEM continues to outpace global car and light truck builds; organic sales declined in electronics due to continued impact of semiconductor constraints on customers • Operating margins -3.2 ppts year-on-year; increases in raw materials and logistics costs, partially offset by sales growth Health Care +3.3% 23.5% • Organic growth led by food safety, oral care, and health information systems; declined in medical solutions due to lower year-on-year disposable respirator sales • Operating margins +0.7 ppts year-on-year; improvement due to sales growth, partially offset by rising raw materials and logistics costs Consumer +7.6% 21.7% • Continued strength in home improvement and home cleaning; improving office and stationery demand driven by return-to-school • Operating margins -2.6 ppts year-on-year; increases in raw materials, logistics, outsourced hardgoods manufacturing costs, partially offset by sales growth -- 8 of 16 -- 99 2021 Q3 Earnings – October 26, 2021. All rights reserved. 2021 planning estimates Macro and business trends Q4 vs. Q3 2021 sequential items of note • Global end-market demand remains strong • Semiconductor constraints impacting end-markets, particularly automotive and electronics • Healthcare and oral care elective procedures expected to remain stable with recent trends • Significant global supply chain, raw materials and logistics challenges expected to persist into foreseeable future • Full-year raw material and logistics headwinds of $0.80 to $0.90 per share, responding with selling price increases, dual sourcing and yield improvement • Maintaining strong execution and operating rigor • One fewer business day versus Q3 2021 • Focused on serving customers while navigating supply chain, raw materials and logistics challenges • Selling price expected to continue to gain traction • Lower pandemic-related disposable respiratory demand of $25M to $75M sequentially ($125M to $175M year-on-year) • Expecting increase in legal-related costs • Previously announced (Dec 2020) restructuring program on track, expected Q4 pre-tax charge of $25M to $50M, similar to Q3 2021 • Higher investments in growth, productivity and sustainability Organic local-currency growth 8% to 9% vs. 6% to 9%, prior Earnings per share $9.70 to $9.90 vs. $9.70 to $10.10, prior Free cash flow conversion 90% to 100%, unchanged -- 9 of 16 -- 10 10 2021 Q3 Earnings – October 26, 2021. All rights reserved. Q&A Mike Roman Chairman of the Board & Chief Executive Officer Monish Patolawala Executive Vice President, Chief Financial & Transformation Officer Bruce Jermeland Senior Vice President, Investor Relations -- 10 of 16 -- 1111 2021 Q3 Earnings – October 26, 2021. All rights reserved. Appendix -- 11 of 16 -- 12 12 2021 Q3 Earnings – October 26, 2021. All rights reserved. Q3 2021 P&L ($M) Q3 2020 Q3 2021 Change Sales $8,350 $8,942 +7.1% Gross profit $4,047 $4,089 +1.0% % to sales 48.5% 45.7% -2.8 pts SG&A $1,677 $1,819 +8.4% % to sales 20.1% 20.3% +0.2 pts R&D & related $461 $482 +4.4% % to sales 5.5% 5.4% -0.1 pts Gain on sale of businesses — — — % to sales — — — Operating income $1,909 $1,788 -6.3% % to sales 22.9% 20.0% -2.9 pts Net income $1,430 $1,434 +0.3% GAAP earnings per share $2.45 $2.45 -0.3% -- 12 of 16 -- 13 13 2021 Q3 Earnings – October 26, 2021. All rights reserved. Q3 2021 sales recap Americas EMEA APAC Worldwide Organic volume +5.4% +3.1% +5.1% +4.9% Price +2.0% +1.1% +0.5% +1.4% Organic local-currency +7.4% +4.2% +5.6% +6.3% Acquisitions/divestitures —% —% —% —% FX +0.5% +1.0% +1.2% +0.8% Total growth +7.9% +5.2% +6.8% +7.1% U.S. Canada Mexico Brazil China/HK Japan Organic local-currency +6% +7% +12% +22% +3% +6% -- 13 of 16 -- 14 14 2021 Q3 Earnings – October 26, 2021. All rights reserved. Business segment information ($M) Net Sales Q3 2021 Sales Growth Organic local-currency by Geographic Area Business Segment Operating Income/Adjusted Operating Income* Business Segment Operating Margin/Adjusted Operating Margin* Business groups Q3 2020 Q3 2021 Organic local- currency FX M&A Total Sales Change Americas Asia Pacific EMEA Q3 2020 Q3 2021 Percent change Q3 2020 Q3 2021 Safety & Industrial $3,017 $3,235 6.1% 1.1% —% 7.2% 4.9% 15.6% -0.8% $774 $620 -19.9% 25.7% 19.2% Transportation & Electronics $2,316 $2,450 5.1% 0.7% —% 5.8% 13.3% -0.2% 11.3% $514 $465 -9.4% 22.2% 19.0% Health Care $2,160 $2,249 3.3% 0.8% —% 4.1% 1.4% 10.9% 3.1% $493 $529 7.2% 22.8% 23.5% Consumer $1,412 $1,525 7.6% 0.5% —% 8.1% 9.5% 3.8% -0.6% $343 $332 -3.3% 24.3% 21.7% Elimination of Dual Credit $(553) $(520) $(142) $(131) Total Operating Business Segment $1,982 $1,815 Corporate & Unallocated $(2) $3 $(73) $(27) Total $8,350 $8,942 6.3% 0.8% —% 7.1% 7.4% 5.6% 4.2% $1,909 $1,788 -6.3% 22.9% 20.0% * “Corporate and Unallocated” and “Total” provided on an adjusted basis Organic local-currency = organic volume + price -- 14 of 16 -- 15 15 2021 Q3 Earnings – October 26, 2021. All rights reserved. Additional sales detail ($M) Net Sales Business groups Q3 2020 Q3 2021 Abrasives 289 362 Automotive Aftermarket 308 314 Closure and Masking Systems 242 264 Electrical Materials 285 322 Industrial Adhesives & Tapes 643 760 Personal Safety 1,136 1,105 Roofing Granules 113 109 Other Safety & Industrial 1 (1) Total Safety & Industrial Business Group 3,017 3,235 Advanced Materials 247 305 Automotive & Aerospace 410 439 Commercial Solutions 391 457 Electronics 1,025 1,000 Transportation Safety 245 250 Other Transportation & Electronics (2 ) (1) Total Transportation & Electronics Business Group 2,316 2,450 ($M) Net Sales Business groups Q3 2020 Q3 2021 Drug Delivery — — Food Safety 83 96 Health Information Systems 280 309 Medical Solutions 1,251 1,241 Oral Care 320 359 Separation & Purification Sciences 221 244 Other Health Care 5 — Total Health Care Business Group 2,160 2,249 Consumer Health & Safety 139 152 Home Care 268 278 Home Improvement 644 699 Stationery & Office 318 355 Other Consumer 43 41 Total Consumer Business Group 1,412 1,525 Corporate & Unallocated (2) 3 Elimination of Dual Credit (553) (520) Total 8,350 8,942 -- 15 of 16 -- -- 16 of 16 --